SirenLabs is FitLife's innovative new line of high-quality nutritional supplements, available exclusively at GNC®. Launched in June of this year, SirenLabs' products are already available at approximately 98% of our top 100 customer's retail locations.

"SirenLabs' performance to date has exceeded my high expectations. In addition to rapid customer account penetration, the SirenLabs line is on pace to post revenue of $1 million for the fiscal year ended December 31, 2013," said John S. Wilson, FitLife's Chief Executive Officer. "SirenLabs is another example of our company's overall growth strategy and is a critical element of our focus on developing and marketing truly innovative nutritional supplements on a global basis."

"Sustained brand and product differentiation allows us to offer a broader suite of effective solutions to our loyal customers while simultaneously enhancing product visibility and awareness. This equates to increased revenue as well as the opportunity to exploit economies of scale, both of which should help drive increased shareholder value," concluded Mr. Wilson.

About FitLife BrandsFitLife Brands is a manufacturer of innovative and proprietary nutritional supplements for health conscious consumers marketed primarily through its wholly owned operating divisions. FitLife sells over 50 different dietary supplements to promote sports nutrition, improved performance, weight loss and general health primarily through GNC® franchises. Concurrent with the September 2013 recapitalization, the corporate name of the company was changed from Bond Labs, Inc. to FitLife Brands, Inc. FitLife is headquartered in Omaha, Nebraska. For more information please visit our new website at www.fitlifebrands.com

Forward-Looking StatementStatements in this release that are forward looking involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to be materially different from any future performance that may be suggested in this news release. Such factors may include, but are not limited to: the ability to of the Company to continue to grow revenue; and the Company's ability to continue to achieve positive cash flow given the Company's existing and anticipated operating and other costs. Many of these risks and uncertainties are beyond the Company's control. Reference is made to the discussion of risk factors detailed in The Company's filings with the Securities and Exchange Commission including its reports on Form 10-K and 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.